CLB FY 2016 Earnings Report — Core Laboratories N.V. Revenue & Financial Results | Market Cap Arena

Core Laboratories N.V.CLB

FY 2016 Earnings

Reported February 10, 2017

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2016	Prior Q	FY 2015	QoQ Change	YoY Change
Revenue	$595M	—	$798M	—	-25.4%
Op. Income	$86M	—	$161M	—	-46.5%
Gross Margin	21.1%	—	29.8%	—	-8.7pp
Net Margin	10.7%	—	14.4%	—	-3.7pp
EPS (Diluted)	$1.45	—	$2.68	—	-45.9%
Free Cash Flow	$120M	—	$195M	—	-38.3%

Revenue Flow

Item	Amount
REVENUE	$595M
Cost of Revenue	$470M
GROSS PROFIT	$125M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$39M
SG&A Expenses	$39M
Other Expenses	$344.0K
Operating Expenses	$39M
Cost & Expenses	$509M
OPERATING INCOME	$86M
Interest Income	$0
Interest Expense	$12M
Other Income/Expenses	-$12M
INCOME BEFORE TAX	$75M
Income Tax Expense	$11M
Net Income from Continuing Ops	$65M
Net Income from Discontinued Ops	$0
Other Adjustments	-$1M
NET INCOME	$64M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$64M
D&A	$27M
EBIT	$87M
EBITDA	$114M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$595M
Cost of Revenue	$470M
GROSS PROFIT	$125M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$39M
SG&A Expenses	$39M
Other Expenses	$344.0K
Operating Expenses	$39M
Cost & Expenses	$509M
OPERATING INCOME	$86M
Interest Income	$0
Interest Expense	$12M
Other Income/Expenses	-$12M
INCOME BEFORE TAX	$75M
Income Tax Expense	$11M
Net Income from Continuing Ops	$65M
Net Income from Discontinued Ops	$0
Other Adjustments	-$1M
NET INCOME	$64M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$64M
D&A	$27M
EBIT	$87M
EBITDA	$114M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$64M
Depreciation & Amortization	$27M
Stock-Based Compensation	$22M
Deferred Income Tax	-$14M
Other Non-Cash Items	-$2M
Change in Working Capital	$35M
OPERATING CASH FLOW	$132M
Capital Expenditure	-$12M
Acquisitions (Net)	-$1M
Purchases of Investments	-$3M
Sales/Maturities of Investments	$0
Other Investing Activities	-$11M
NET CASH FROM INVESTING	-$15M
Net Debt Issuance	-$217M
Common Stock Repurchased	-$7M
Common Dividends Paid	-$95M
Other Financing Activities	-$3M
NET CASH FROM FINANCING	-$125M
FREE CASH FLOW	$120M
Net Change in Cash	-$8M

Balance Sheet

Item	Amount
Cash & Equivalents	$15M
Short-Term Investments	$0
Net Receivables	$114M
Inventory	$34M
Other Current Assets	$13M
TOTAL CURRENT ASSETS	$186M
PP&E (Net)	$130M
Goodwill	$179M
Intangible Assets	$10M
Long-Term Investments	$3M
Tax Assets	$21M
Other Non-Current Assets	-$24M
TOTAL NON-CURRENT ASSETS	$387M
TOTAL ASSETS	$573M
Account Payables	$34M
Short-Term Debt	$0
Deferred Revenue	$16M
Other Current Liabilities	$19M
TOTAL CURRENT LIABILITIES	$104M
Long-Term Debt	$216M
Deferred Revenue NC	-$6M
Deferred Tax Liabilities	$6M
Other Non-Current Liabilities	$91M
TOTAL NON-CURRENT LIABILITIES	$314M
TOTAL LIABILITIES	$418M
Common Stock	$1M
Additional Paid-In Capital	$53M
Retained Earnings	$188M
Treasury Stock	-$81M
Accum. Other Comp. Income	-$10M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$155M
Minority Interest	$4M
TOTAL EQUITY	$159M
TOTAL LIABILITIES & EQUITY	$573M
Total Debt	$216M
Net Debt	$202M